These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20505116)

  • 41. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
    Zhan L; Xiang B; Muthuswamy SK
    Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
    Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis.
    Bertotti A; Comoglio PM; Trusolino L
    Cancer Res; 2005 Dec; 65(23):10674-9. PubMed ID: 16322210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells.
    Bisaro B; Montani M; Konstantinidou G; Marchini C; Pietrella L; Iezzi M; Galiè M; Orso F; Camporeale A; Colombo SM; Di Stefano P; Tornillo G; Camacho-Leal MP; Turco E; Taverna D; Cabodi S; Amici A; Defilippi P
    Breast Cancer Res; 2012 Oct; 14(5):R137. PubMed ID: 23098208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A therapeutic trial of human melanomas with combined small interfering RNAs targeting adaptor molecules p130Cas and paxillin activated under expression of ganglioside GD3.
    Makino Y; Hamamura K; Takei Y; Bhuiyan RH; Ohkawa Y; Ohmi Y; Nakashima H; Furukawa K; Furukawa K
    Biochim Biophys Acta; 2016 Aug; 1860(8):1753-63. PubMed ID: 27068854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.
    Pylayeva Y; Gillen KM; Gerald W; Beggs HE; Reichardt LF; Giancotti FG
    J Clin Invest; 2009 Feb; 119(2):252-66. PubMed ID: 19147981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.
    Allen-Petersen BL; Carter CJ; Ohm AM; Reyland ME
    Oncogene; 2014 Mar; 33(10):1306-15. PubMed ID: 23474764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis.
    Beckers J; Herrmann F; Rieger S; Drobyshev AL; Horsch M; Hrabé de Angelis M; Seliger B
    Int J Cancer; 2005 Apr; 114(4):590-7. PubMed ID: 15609325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p130Cas over-expression impairs mammary branching morphogenesis in response to estrogen and EGF.
    Camacho Leal Mdel P; Pincini A; Tornillo G; Fiorito E; Bisaro B; Di Luca E; Turco E; Defilippi P; Cabodi S
    PLoS One; 2012; 7(12):e49817. PubMed ID: 23239970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14.
    Zhang P; Guo A; Possemato A; Wang C; Beard L; Carlin C; Markowitz SD; Polakiewicz RD; Wang Z
    Oncogene; 2013 Apr; 32(16):2087-95. PubMed ID: 22710723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cas proteins: dodgy scaffolding in breast cancer.
    Tornillo G; Defilippi P; Cabodi S
    Breast Cancer Res; 2014; 16(5):443. PubMed ID: 25606587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation.
    Camacho Leal MDP; Costamagna A; Tassone B; Saoncella S; Simoni M; Natalini D; Dadone A; Sciortino M; Turco E; Defilippi P; Calautti E; Cabodi S
    Cell Commun Signal; 2018 Nov; 16(1):73. PubMed ID: 30390666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of binding phenomenon of NSP3 and p130Cas mutants and their effect on cell signalling.
    Balu K ; Rajendran V; Sethumadhavan R; Purohit R
    Cell Biochem Biophys; 2013 Nov; 67(2):623-33. PubMed ID: 23494262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p130Cas/
    Centonze G; Natalini D; Salemme V; Costamagna A; Cabodi S; Defilippi P
    Front Cell Dev Biol; 2021; 9():729093. PubMed ID: 34708040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low Intensity Ultrasound Induces Epithelial Cell Adhesion Responses.
    Lim J; Chu YS; Chu YC; Lo CM; Wang JL
    J Biomech Eng; 2020 Sep; 142(9):. PubMed ID: 32280990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Src, p130Cas, and Mechanotransduction in Cancer Cells.
    Matsui H; Harada I; Sawada Y
    Genes Cancer; 2012 May; 3(5-6):394-401. PubMed ID: 23226577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Author Correction: The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.
    Grasso S; Chapelle J; Salemme V; Aramu S; Russo I; Vitale N; di Cantogno LV; Dallaglio K; Castellano I; Amici A; Centonze G; Sharma N; Lunardi S; Cabodi S; Cavallo F; Lamolinara A; Stramucci L; Moiso E; Provero P; Albini A; Sapino A; Staaf J; Di Fiore PP; Bertalot G; Pece S; Tosoni D; Confalonieri S; Iezzi M; Di Stefano P; Turco E; Defilippi P
    Nat Commun; 2018 Mar; 9():16203. PubMed ID: 29600801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erratum: Stiffness of the microenvironment upregulates ERBB2 expression in 3D cultures of MCF10A within the range of mammographic density.
    Cheng Q; Bilgin CC; Fontenay G; Chang H; Henderson M; Han J; Parvin B
    Sci Rep; 2016 Aug; 6():31680. PubMed ID: 27555341
    [No Abstract]   [Full Text] [Related]  

  • 59. Endothelial p130cas confers resistance to anti-angiogenesis therapy.
    Wen Y; Chelariu-Raicu A; Umamaheswaran S; Nick AM; Stur E; Hanjra P; Jiang D; Jennings NB; Chen X; Corvigno S; Glassman D; Lopez-Berestein G; Liu J; Hung MC; Sood AK
    Cell Rep; 2023 Mar; 42(3):. PubMed ID: 37274180
    [No Abstract]   [Full Text] [Related]  

  • 60. Endothelial p130cas confers resistance to anti-angiogenesis therapy.
    Wen Y; Chelariu-Raicu A; Umamaheswaran S; Nick AM; Stur E; Hanjra P; Jiang D; Jennings NB; Chen X; Corvigno S; Glassman D; Lopez-Berestein G; Liu J; Hung MC; Sood AK
    Cell Rep; 2022 Jun; 39(12):110999. PubMed ID: 35732127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.